Advertisement
Screener

JUNIPER PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, after Year Five

JUNIPER PHARMACEUTICALS INC Finite-Lived Intangible Asset, Expected Amortization, after Year Five

JUNIPER PHARMACEUTICALS INC had Finite-Lived Intangible Asset, Expected Amortization, after Year Five of $217.00 thousand as of 2015-09-30, per its 10-Q filed 2015-11-12.

Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive · last filed 2015-11-12

  • 2015-09-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $217.00K.
  • 2015-06-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $225.00K.
  • 2015-03-31: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $212.00K.
  • 2014-09-30: Finite-Lived Intangible Asset, Expected Amortization, after Year Five $548.00K.
Period endFinite-Lived Intangible Asset, Expected Amortization, after Year Five
2015-09-30$217.00K
10-Q · filed 2015-11-12
2015-06-30$225.00K
10-Q · filed 2015-08-04
2015-03-31$212.00K
10-Q · filed 2015-05-06
2014-09-30$548.00K
10-Q · filed 2014-10-31